[
  {
    "ts": "2026-01-14T18:27:33+00:00",
    "headline": "JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced",
    "summary": "Henry Schein currently has a broad portfolio with over $3bn in corporate and owned brand products and services.",
    "url": "https://www.medicaldevice-network.com/analyst-comment/jpm26-henry-schein-focuses-on-high-margin-high-growth-business-as-new-ceo-announced/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "70062b32-7739-322c-89fc-7cd06ce88af7",
      "content": {
        "id": "70062b32-7739-322c-89fc-7cd06ce88af7",
        "contentType": "STORY",
        "title": "JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced",
        "description": "",
        "summary": "Henry Schein currently has a broad portfolio with over $3bn in corporate and owned brand products and services.",
        "pubDate": "2026-01-14T18:27:33Z",
        "displayTime": "2026-01-14T18:27:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/f399538530b6e877d031e818db7151c8",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfXB7ujLEwQnFtL1KUrRQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/f399538530b6e877d031e818db7151c8.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3SsM6vGnXyFKQRUX.pavjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/f399538530b6e877d031e818db7151c8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/analyst-comment/jpm26-henry-schein-focuses-on-high-margin-high-growth-business-as-new-ceo-announced/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-henry-schein-focuses-high-182733394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSIC"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-14T22:17:00+00:00",
    "headline": "Biomerica Reports Second Quarter Fiscal 2026 Financial Results",
    "summary": "Operating Expenses Decline 4% Year-to-DateBalance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2026 ended November 30, 2025. Key Highlights: 1.Biomerica Expands Commercialization of inFoods® IBS Through Collaboration with Henry Schein During the secon",
    "url": "https://finance.yahoo.com/news/biomerica-reports-second-quarter-fiscal-221700508.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "50b8add7-6621-3248-9354-7b3a57d85641",
      "content": {
        "id": "50b8add7-6621-3248-9354-7b3a57d85641",
        "contentType": "STORY",
        "title": "Biomerica Reports Second Quarter Fiscal 2026 Financial Results",
        "description": "",
        "summary": "Operating Expenses Decline 4% Year-to-DateBalance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2026 ended November 30, 2025. Key Highlights: 1.Biomerica Expands Commercialization of inFoods® IBS Through Collaboration with Henry Schein During the secon",
        "pubDate": "2026-01-14T22:17:00Z",
        "displayTime": "2026-01-14T22:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/f4e07c2f280d0c40d37cf49c5ec5af6c",
          "originalWidth": 232,
          "originalHeight": 39,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m.JFSTv_vwJxX856oVblMg--~B/aD0zOTt3PTIzMjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/f4e07c2f280d0c40d37cf49c5ec5af6c.cf.webp",
              "width": 232,
              "height": 39,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YH21BNHGg8W0yXRmtOUHQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f4e07c2f280d0c40d37cf49c5ec5af6c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biomerica-reports-second-quarter-fiscal-221700508.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biomerica-reports-second-quarter-fiscal-221700508.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMRA"
            },
            {
              "symbol": "HSIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]